Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F57MA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,056
Award facts
- Contract value 100% obligated
- $33,055.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $33,055.74 to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of BIKTARVY 50-200-25 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 21, 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2031, serving as the primary vehicle for supplying pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen operates as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the Defense Logistics Agency. The company's extensive portfolio demonstrates capability across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. The delivery order for BIKTARVY, an antiretroviral medication used in HIV treatment regimens, reflects the company's role in supplying essential prescription medications to support military treatment facilities and federal healthcare institutions. All of AmerisourceBergen's reviewed federal contract awards have been competitively awarded with firm fixed pricing structures, demonstrating its consistent qualification to meet federal procurement requirements.
Quick answers
Who was awarded contract SPE2DR26F57MA?
SPE2DR26F57MA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F57MA worth?
The government has obligated $33,056 on SPE2DR26F57MA.
Is contract SPE2DR26F57MA an order under another contract?
Yes. SPE2DR26F57MA is a delivery order under SPE2DR25D2006, an indefinite delivery contract.
Was contract SPE2DR26F57MA competed?
The extent of competition for SPE2DR26F57MA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award